BioVaxys Technology (BioVaxys Technology) Operating Cash Flow per Share : $-0.01 (TTM As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Operating Cash Flow per Share?

BioVaxys Technology's operating cash flow per share for the three months ended in Jul. 2023 was $0.00. BioVaxys Technology's operating cash flow per share for the trailing twelve months (TTM) ended in Jul. 2023 was $-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for BioVaxys Technology's Operating Cash Flow per Share or its related term are showing as below:

BVAXF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 10.1 Med: 10.1 Max: 10.1
Current: 10.1

During the past 5 years, BioVaxys Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 10.10% per year. The lowest was 10.10% per year. And the median was 10.10% per year.

BVAXF's 3-Year OCF Growth Rate is ranked better than
56.37% of 1233 companies
in the Biotechnology industry
Industry Median: 3.5 vs BVAXF: 10.10

BioVaxys Technology Operating Cash Flow per Share Historical Data

The historical data trend for BioVaxys Technology's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Operating Cash Flow per Share Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Operating Cash Flow per Share

-0.02

-0.03

-0.05

-0.01

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioVaxys Technology's Operating Cash Flow per Share

For the Biotechnology subindustry, BioVaxys Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVaxys Technology's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Price-to-Operating-Cash-Flow falls into.

BioVaxys Technology Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

BioVaxys Technology's Operating Cash Flow per Share for the fiscal year that ended in Oct. 2022 is calculated as

Operating Cash Flow per Share (A: Oct. 2022 )	=	Cash Flow from Operations (A: Oct. 2022 )	/	Shares Outstanding (Diluted Average) (A: Oct. 2022 )
	=	-1.151	/	98.180
	=	-0.01

BioVaxys Technology's Operating Cash Flow per Share for the quarter that ended in Oct. 2022 is calculated as

Operating Cash Flow per Share (Q: Jul. 2023 )	=	Cash Flow from Operations (Q: Jul. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jul. 2023 )
	=	-0.018	/	146.815
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

BioVaxys Technology Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.